Lau-Cam C A, Piemontese D
St John's University, College of Pharmacy and Allied Health Professions, Jamaica, New York 11439, USA.
J Pharm Biomed Anal. 1998 Feb;16(6):1029-35. doi: 10.1016/s0731-7085(97)00117-9.
A high-performance liquid chromatographic (HPLC) method was developed for the assay of verapamil in rat plasma. After deproteinization of the plasma sample with an acetonitrile-perchloric acid (8:2) mixture containing dextromethorphan, the internal standard, an aliquot of the supernatant was directly analyzed on a cyanopropylsilane column with methanol-acetonitrile-triethylamine acetate buffer (10:30:60) as the mobile phase and detection at 235 mm. At a flow rate of 1.5 ml min-1, a complete analysis was completed in less than 6 min. The method was linear for verapamil concentrations in the range 0.5-10 micrograms ml-1 (r = 0.9999). Recoveries for the same drug concentrations from spiked rat plasma ranged from 85.6-93.0% (n = 8). The mean RSD values for intraday and interday assay reproducibility (n = 3) were, in both cases, less than 0.9%. The limit of detectability was about 0.1 microgram ml-1. The method was found useful to monitor the plasma levels of verapamil in rats that had received this drug by the nasal, oral and intravenous routes of administration.
建立了一种高效液相色谱(HPLC)法测定大鼠血浆中的维拉帕米。用含右美沙芬(内标)的乙腈 - 高氯酸(8:2)混合物对血浆样品进行去蛋白处理后,取上清液的一份等分试样,直接在氰丙基硅烷柱上进行分析,以甲醇 - 乙腈 - 三乙胺乙酸缓冲液(10:30:60)作为流动相,在235 nm处检测。流速为1.5 ml min-1时,不到6分钟即可完成一次完整分析。该方法在维拉帕米浓度为0.5 - 10微克ml-1范围内呈线性(r = 0.9999)。加标大鼠血浆中相同药物浓度的回收率为85.6 - 93.0%(n = 8)。日内和日间测定重现性(n = 3)的平均相对标准偏差(RSD)值在两种情况下均小于0.9%。检测限约为0.1微克ml-1。该方法被证明可用于监测经鼻、口服和静脉给药途径给予维拉帕米的大鼠的血浆水平。